Skip to main content

Trophoblast cell differentiation in the bovine placenta: differentially expressed genes between uninucleate trophoblast cells and trophoblast giant cells are involved in the composition and remodeling of the extracellular matrix and O-glycan biosynthesis



In the bovine placenta, intimate fetomaternal contacts are restricted to discrete placentomes. Here, widely branched fetal chorionic villi interdigitate with corresponding maternal caruncular crypts. The fetal trophoblast epithelium covering the chorionic villi consists of approximately 80% uninucleate trophoblast cells (UTCs) and 20% binuclear trophoblast giant cells (TGCs). The weakly invasive TGCs migrate toward the caruncle epithelium and eventually fuse with individual epithelial cells to form short-lived fetomaternal hybrid cells. In this way, molecules of fetal origin are transported across the placental barrier and released into the maternal compartment. The UTC/TGC ratio in the trophoblast remains almost constant because approximately as many new TGCs are produced from UTCs as are consumed by the fusions. The process of developing TGCs from UTCs was insufficiently understood. Therefore, we aimed to detect differentially expressed genes (DEGs) between UTCs and TGCs and identify molecular functions and biological processes regulated by DEGs.


We analyzed gene expression patterns in virtually pure UTC and TGC isolates using gene arrays and detected 3193 DEGs (p < 0.05; fold change values < − 1.5 or > 1.5). Of these DEGs, 1711 (53.6%) were upregulated in TGCs and 1482 (46.4%) downregulated. Gene Ontology (GO) analyses revealed that molecular functions and biological processes regulated by DEGs are related to the extracellular matrix (ECM) and its interactions with cellular receptors, cell migration and signal transduction. Furthermore, there was some evidence that O-glycan biosynthesis in TGCs may produce sialylated short-chain O-glycans (Tn antigen, core 1 O-glycans), while the synthesis of other O-glycan core structures required for the formation of complex (i.e., branched and long-chain) O-glycans appears to be decreased in TGCs.


The differentiation of UTCs into TGCs particularly regulates genes that enable trophoblast cells to interact with their environment. Significant differences between UTCs and TGCs in ECM composition indicate reduced anchoring of TGCs in the surrounding matrix, which might contribute to their migration and their weakly invasive interaction with the maternal endometrium. Furthermore, increased expression of sialylated short chain O-glycans by TGCs could facilitate the modulation of maternal immune tolerance.


The placenta forms the interface between the fetus and mother. Despite specific anatomical and histological differences among species, the basic functions of the placenta are largely the same: anchoring of the fetus in the uterus, supply of nutrients to the fetus, gas exchange and elimination of fetal waste products. In addition, the placental barrier protects the fetus from harmful substances. By inducing local immune tolerance, the placenta prevents the rejection of the fetus by the mother [1].

The bovine placenta is also an important endocrine organ. The trophoblast autonomously produces significant amounts of estrogens which play a role in softening the birth canal before birth and preparing the mammary gland for lactation. Placental estrogens may also act as local regulators of growth and development of the placenta itself. Furthermore, the placenta is a source of pregnancy-specific peptide hormones, namely, placenta lactogen (PL) and prolactin-related protein I (PRP-I), representing the placental counterparts of the pituitary hormone prolactin (PRL). PL regulates reproductive physiological processes in the uterus and mammary gland and further promotes the release of nutrients from the maternal to the fetal compartment. Remarkably, the functions of PRP-I have not been determined to date (reviewed by [2]). The most conspicuous structures of the bovine placenta are the mushroom-shaped placentomes, which are composed of the fetal chorion and the maternal caruncle. The chorion forms widely ramified villi that protrude into corresponding crypts of the caruncles, resulting in a greatly enlarged fetomaternal contact surface [3,4,5]. The chorionic villi are covered by the trophoblast epithelium consisting of 80% uninucleate trophoblast cells (UTCs) and 20% binuclear trophoblast giant cells (TGCs), which have a rounded shape and are scattered between the UTCs. The UTC/TGC ratio remains almost constant throughout pregnancy until shortly before birth [6]. UTCs show typical epithelial cell features, being attached to the trophoblast basal lamina and exhibiting tight junctions to neighboring UTCs, creating the placental barrier. The apical surface of UTCs facing the caruncular epithelium exhibits microvilli, thereby also enhancing fetomaternal contacts [6, 7]. TGCs are not connected to the trophoblast basal lamina and do not contribute to the apical surface of the trophoblast epithelium. The two nuclei of TGCs are polyploid as a consequence of acytokinetic mitoses [8, 9]. The cytoplasm of TGCs encloses numerous granules containing different kinds of fetal secretory glycoproteins, such as pregnancy-associated glycoproteins (PAGs), PL and PRP-I [6, 10]. TGCs are capable of migrating toward the maternal compartment and traversing the placental barrier. Eventually, TGCs fuse with single caruncular epithelial cells to form short-lived fetomaternal hybrid cells that deliver their cytoplasmic granules into the maternal compartment. After degranulation, hybrid cells become apoptotic and are eventually resorbed by the trophoblast [6]. The resulting loss of TGCs is compensated by new TGCs formed from UTCs by differentiation. During this process, intermediate developmental stages occur that differ in size, level of polyploidy, abundance of cytoplasmic granules and location in the trophoblast epithelium [8, 9]. Because TGCs do not cross the uterine basal membrane and the opposing chorionic and caruncular epithelial layers remain intact, the bovine placenta is classified as synepitheliochorial [6, 7]. Numerous studies have provided profound knowledge on the morphology and histology of the ruminant placenta and its endocrine and other physiological functions. However, our knowledge of the differentiation of UTCs into TGCs at the gene expression level was sparse. Only after the development of a preparative method for the isolation of virtually pure UTCs and TGCs from bovine placentas [11] did a genome-wide gene expression study on trophoblast cell differentiation become feasible.

The aim of this work was to identify differentially expressed genes (DEGs) between UTCs and TGCs and to gain preliminary insights into biological processes, molecular functions and pathways associated with DEGs through gene ontological (GO) analyses.


Gene expression profiles of UTCs and TGCs

Although the sorted UTCs and TGCs were virtually pure and appeared to be morphologically sound [11], their natural gene expression patterns may have been distorted during the long preparation procedure. To address this issue, we used qPCR to measure the transcript abundance of the TGC marker genes RUM1 and BERV-K1 in the two trophoblast cell populations. The retroviral RUM1 and BERV-K1 genes encode placenta-specific membrane glycoproteins, syncytins, which are involved in the fusion of TGCs with caruncle epithelial cells [12]. Indeed, both transcripts were more abundant in TGCs than in UTCs (Fig. 1). Subsequently, we analyzed genome-wide transcripts of UTCs and TGCs in a microarray approach. A hierarchical cluster analysis showed the correct assignment of the microarray expression data sets to the UTC and TGC groups (Fig. 2). We identified 3193 DEGs, 1711 (53.6%) of which were upregulated in TGCs, and 1482 (46.6%) of which were downregulated (Additional file 1: Table S1-A). In this study, we refer to genes as upregulated when their transcripts were more abundant in TGCs than in UTCs. Accordingly, genes whose transcript amounts were lower in TGCs than in UTCs were regarded as downregulated. We evaluated the micorarray measurements with a spot check by reanalyzing 15 transcripts with qPCR and found that both methods provided largely consistent results (Fig. 3; Additional file 1: Table S1-B).

Fig. 1

Relative abundance of RUM1 and BERV-K1 transcripts in the UTC and TGC isolates. Mean values ± SEM of n = 3 independent measurements and the p-values from t-tests are shown

Fig. 2

Hierarchical cluster analysis of the microarray data. Dendrogram of clustering individual samples of UTC and TGC preparations using centered correlation and average linkage. The dendrogram is based on all data as obtained after the GCRMA normalization. The numbers (#2, #3 and #4) refer to the individual animals [11] from which the trophoblast cells originate

Fig. 3

Validation of microarray measurements by qPCR. Fold change values compare TGCs vs. UTCs

KEGG pathways and GO terms associated with DEGs

First, we were interested in identifying KEGG pathways that possibly play significant roles during the differentiation of UTCs into TGCs. To this end, we searched the KEGG database for associations with DEGs using the DAVID functional annotation tool. Our DAVID-compliant DEG list included 2595 genes (DAVID IDs) (Additional file 1: Table S1-C). The significance of the identified KEGG pathways is indicated by a p-value, which depends on the number of associated DEGs. KEGG pathways were considered to be highly regulated by DEGs when the p-values were < 0.01 and the Benjamini values were < 0.1 (Table 1).

Table 1 KEGG pathways associated with DEGs between UTCs and TGCs

Furthermore, we attempted to discover biological processes and molecular functions that are relevant for the formation of TGCs from UTCs. To this end, we performed functional annotation clustering, which combines similar GO terms into annotation clusters (ACs) based on the number of shared DEGs. The ranking of the ACs is based on annotation enrichment scores, which result from the individual p-values of the GO terms involved. The assumption is that clusters with the highest enrichment scores indicate the most relevant molecular functions and biological processes. The 15 top-ranking ACs are listed in Table 2.

Table 2 Annotation clusters (ACs) of DEG-associated GO terms


This first genome-wide gene expression study on UTCs and TGCs of bovine trophoblasts was made possible by the availability of virtually pure cell isolates after a FACS-based purification procedure [11]. The aim of this study was to contribute to a deeper understanding of the differentiation processes involved in the formation of TGCs from UTCs in the bovine trophoblast epithelium. By identifying and analyzing DEGs between UTCs and TGCs, we have obtained evidence of molecular functions, biological processes and pathways that are likely to play important roles in the formation of TGCs.

Evaluation of the integrity of gene expression patterns in UTCs and TGCs

Evidence from the measurements of the TGC marker transcripts RUM1 and BERV-K1 indicated that natural gene expression patterns of UTCs and TGCs did not change substantially during the preparative procedure. This conclusion is further supported by the PAG gene expression patterns resulting from the microarray data. Of more than 20 known PAG genes present in the bovine genome, 17 were differentially expressed in UTCs and TGCs (Table 3; Additional file 1: Table S1-A).

Table 3 Expression of PAG genes in UTCs and TGCs. Comparison of expression sites revealed by microarray experiments and published data by others

Previous in situ hybridization and immunostaining analyses showed a different cellular distribution of ancient and modern PAGs [13] in the trophoblast epithelium, where ancient PAGs were localized mainly in UTCs and in a small number of TGCs, while modern PAGs were restricted to TGCs [14, 16, 17]. In accordance with the published data, the modern PAG genes were all upregulated in TGCs, while the ancient PAG genes PAG2, PAG8 and PAG12 were downregulated in TGCs. Interestingly, PAG10 was also upregulated in TGCs, although it is an ancient PAG. However, this observation is consistent with recent results obtained from immunolocalization experiments by Wallace et al. [16]. Only PAG11 localization experiments yielded inconsistent results: in situ hybridization [14] and microarray results indicate that UTCs are PAG11-producing cells, whereas PAG11 immunostaining was restricted to TGCs [15]. In summary, it can be concluded that our UTCs and TGCs were suitable for microarray experiments. In addition, such UTC and TGC isolates should also be useful for future proteome analyses that could not be performed in this study due to the insufficient number of cells.

DEGs involved in endocrine functions of the bovine placenta

The bovine placenta is capable of producing estrogens independently of the external supply of C19 precursors, as it expresses all enzymes needed to convert cholesterol into estrogens: side chain cleavage enzyme (CYP11A1), steroid 17-alpha-hydroxylase/17,20 lyase (CYP17A1), 3 beta-hydroxysteroid dehydrogenase/Delta 5➔4-isomerase (HSD3B1) and aromatase (CYP19A1) (reviewed by [2]). We searched our microarray data for the expression of the respective transcripts and found that all were downregulated in TGCs (Additional file 1: Table S1-A) with fold-change values of − 4.17 (CYP11A1), − 3.85 (CYP17A1), − 1.85 (HSD3B1) and − 3.85 (CYP19A1). The strong downregulation of CYP11A1 and CYP17A1 transcripts during TGC development is consistent with previous observations by other groups. Ben David et al. [18] used immunoelectron microscopy and detected CYP11A1-specific signals only in UTCs, and CYP17A1 was immunolocalized only in UTCs [19]. Shortly after UTCs entered the TGC pathway, both enzymes were no longer detectable. The small difference between UTCs and TGCs in HSD3B1 expression seems to contradict earlier results from in situ hybridization experiments that showed the staining of immature TGCs, while mature TGCs and UTCs were negative [18]. However, because our FACS procedure was designed to collect UTCs and mature TGCs, the proper HSD3B1-expressing cells, namely, the developing TGCs, were likely underrepresented in our TGC isolates. The strong downregulation of CYP19A1 mRNA in TGCs detected by our measurements contradicted the immunolocalization of the CYP19A1 protein in immature and mature TGCs but not UTCs [19, 20]. In previous experiments we observed a strong decline only in CYP19A1 transcripts in primary cultures of bovine trophoblast cells, although CYP19A1 transcripts were clearly detectable in freshly dissociated cells [21]. The cause of the contradictory results has not been determined, but we suspect that CYP19A1 expression is particularly sensitive to environmental changes during cell isolation.

The GH/PRL hormones regulate numerous physiological processes related to reproduction and lactation in many mammalian species, including cattle [22]. The bovine GH/PRL gene family comprises one GH and one PRL gene each, both expressed in the pituitary gland, and derivatives of the PRL gene (CSH2, PRPs) expressed in the placenta [2, 23, 24]. The DEGs encoding placenta-expressed GH/PRL representatives were all upregulated in the TGCs (Table 4; Additional file 1: Table S1-A).

Table 4 DEGs encoding members of the PRL family of hormones

Notably, our microarray data showed evidence of placental expression of PRL, mainly in the TGCs. This expression has not been observed in cattle to date. However, placental expression of PRL in TGCs has also been immunologically demonstrated in a giraffe [25] and in elephants [26]. Similar to extrapituitary PRL expression in various human tissues, which is regulated by a nonpituitary PRL promoter [27, 28], PRL expression in bovine placenta could also use a previously unknown nonpituitary PRL promoter. Placenta PRL could exert local functions that differ from the endocrine effects of pituitary PRL.

Findings from GO analyses of DEGs

The results of GO term enrichment analyses (Tables 1 and 2) indicate that the differentiation of UTCs in TGCs particularly regulates genes that enable trophoblast cells to interact with their environment (GO terms are “ECM receptor interaction”, “mucin-type O-glycan biosynthesis”, “cell-matrix adhesion” and “regulation of small GTPase-mediated signal transduction”) or that probably play a role in the migration of TGCs (GO terms are “regulation of cell migration”, “focal adhesion”). In the following discussion, we will focus in more detail on ECM-receptor interactions and mucin-type O-glycan biosynthesis.

ECM-receptor interactions: The ECM forms the scaffold and the microenvironment for the cellular components of tissues and is subject to continuous remodeling processes. In addition, the ECM provides biochemical and biomechanical signals essential for tissue morphogenesis and differentiation. (reviewed by [29]). The main macromolecular components of the ECM are fibrous proteins, such as collagens and laminins, as well as proteoglycans. Some components of collagen I (ColI), ColVI and laminins are encoded by DEGs (Table 5).

Table 5 DEGs associated with the KEGG pathway “ECM receptor interaction”

ColI consists of α1(I) and α2(I) chains in a stoichiometric ratio of 2:1 [30]. The corresponding genes, COL1A1 and COL1A2, are both downregulated in the TGCs, probably leading to decreased ColI production, as well. ColVI is predominantly present in the basal lamina. ColVI is a heterotrimeric protein consisting of α1(VI), α2(VI) and α3(VI) subunits [31]. ColVI filaments interact with many other ECM components, including ColI and the ColIV network of the basal lamina. In addition, ColVI filaments interact with the cell surface via integrins [31, 32]. ColVI filaments thus establish the biomechanical connection between cells and ECM. In TGCs, COL6A1, encoding the α1(VI) subunit, is downregulated. An earlier study in mice showed that the targeted inactivation of COL6A1 (COL6A1 −/−) led to a ColVI-null phenotype [33]. Therefore, the production of ColVI heterotrimers in TGCs is likely to be decreased. Laminins are the major noncollageneous component of the basal lamina and play vital roles in cell differentiation, migration and adhesion. Various domains of the laminin subunits enable interactions with other macromolecules, such as the ColIV network, and with plasma membrane receptors, e.g., dystoglycan and integrins [32, 34]. Laminins consist of α, β and γ chains, which in bovines are encoded by five LAMA genes, three LAMB genes and three LAMC genes. LAMA2, LAMA3 and LAMB1 are downregulated in TGCs (Table 5). Consequently, the formation of laminin heterotrimers with α1, α2 and β1 subunits in TGCs may also be reduced. This reduction would affect 10 of the 15 naturally occurring laminin types, namely, α1/β1/γ1, α2/β1/γ1, α2/β2/γ1, α3/β2/γ1, α3/β2/γ1, α3/β2/γ1, α3/β3/γ2, α3/β1/γ1, α3/β2/γ1, α4/β1/γ1, α5/β1/γ1, α2/β1/γ3 and α3/β2/γ3 [35].

In addition, some integrin-encoding genes were DEGs (Table 5). Integrins are heterodimeric molecules consisting of an α and a β subunit. Both subunits are transmembrane proteins. Integrins mediate cell-cell interactions, anchor cells to the ECM and connect the intracellular actin cytoskeleton to the ECM, thereby mediating both outside-in and inside-out signal transduction. Integrin-mediated cell adhesion plays an important role in controlling cell migration and differentiation [36]. DEG-encoded integrins are constituents of the α1/β1, α2/β1, α6/β1, α11/β1, α6/β4 and αV/β5 integrin receptors [32]. According to the integrin gene expression data, UTCs produce α6/β1, α11/β1, α6/β4 and αV/β5 integrin receptors that are reduced during TGC formation. In contrast, mature TGCs exhibit more α1/β1 and α2/β1 integrins than UTCs. Notably, these integrins are collagen and/or laminin receptors, except for αV/β5 integrin, which binds osteopontin [32]. The results from studies on human placental cytotrophoblasts (CTBs) suggest that the expression of α1/β1 integrin may play a role in the development of the weakly invasive phenotype of TGCs: invasive CTBs also carry α1/β1 integrin receptors on their surface [37], and α1/β1 integrin receptors are necessary for the invasive migration of CTBs [38]. Similar to UTCs, CTB stem cells that are anchored to the basal lamina of the trophoblast epithelium display α6/β4 integrin receptors that disappear when differentiated into invasive CTBs [37, 38]. Integrin switching in CTBs (α6/β4 is downregulated, and α1/β1 is upregulated) is transcriptionally regulated [38]. Immunohistochemical analyses of various ECM proteins and integrin receptors in bovine placentomes showed strong staining of α6 integrin in UTCs and moderate cytoplasmic staining of α2 integrin in TGCs [39], which is consistent with our microarray data. In addition, strong α6 integrin staining along the cytoplasmic membrane of TGCs was detected, which contradicts the observed downregulation of ITGA6 transcripts in TGCs.

In addition to the ECM proteins and integrin receptors, enzymes involved in ECM remodeling and modification of cell surface or secreted molecules, including heparanase, metalloproteinases (MMPs, ADAMs, ADAMTSs) and tissue inhibitors of metalloproteinases (TIMPs) [40,41,42,43], were encoded by DEGs (Table 6).

Table 6 DEGs encoding ECM-modifying enzymes/proteinases and TIMPs

Taken together, our data suggest that there are profound differences between UTCs and TGCs regarding their interactions with the surrounding ECM, signal transduction between the ECM and the actin cytoskeleton and downstream processes. The clearly reduced anchoring of TGCs in the surrounding matrix may be related to their migration and weakly invasive phenotype.

Mucin-type O-glycan biosynthesis: Many proteins, whether secreted or bound to cell surfaces, are O-glycosylated [44]. It is therefore remarkable that our microarray data demonstrate significant regulation of the first steps of O-glycan biosynthesis during the formation of TGCs. The underlying DEGs are shown in Table 7.

Table 7 DEGs related to O-glycan biosynthesis

The products of these first O-glycan biosynthesis steps are basic O-glycan structures, namely, the Tn antigen and four core O-glycans [45] (Fig. 4). The initiating reaction is the coupling of N-acetylgalactosamine (GalNAc) to serine and threonine residues of proteins catalyzed by many isoforms of polypeptide N-acetylgalactosaminyltransferases (GalNTs) (Fig. 4, reaction 1). These GalNT isoforms differ in substrate specificity, compartmentation and expression regulation, and might provide an additional level of regulation for the initiation of O-glycan biosynthesis [46]. The GalNTs fall into two phylogenetically defined groups, which have different substrate preferences: group I enzymes prefer unmodified peptides, while group II enzymes act on modified peptides [46]. Some of the GalNT genes (GALNTs) were identified as DEGs in our microarray study (Table 7). Notably, upregulated (GALNT3 and GALNT6) and downregulated genes (GALNT4, GALNT7 and GALNT10) belong to different groups, suggesting different targets for O-glycosylation in UTCs and TGCs. The upregulation of C1GALT1 and ST3GAL1 in TGCs (Table 7) may lead to an increased production of core 1 and sialylated core 1 O-glycans (Fig. 4, reactions 2 and 6). Sialylated core 1 O-glycans cannot be further extended [45]. In this context, it should be noted that the overexpression of ST3GAL1 is discussed to promote, for instance, tumorigenesis in breast carcinomas [47]. In contrast to the sialylated core 1 O-glycans, the biosynthesis of all other core O-glycans (i.e., cores 2, 3 and 4) is probably downregulated in TGCs (Fig. 4, reactions 3, 4 and 5), as shown by the downregulation of the respective genes (Table 7). Thus, the conversion of UTCs into TGCs is accompanied by a profound structural change in the produced O-glycans: UTCs express all required core structures for complex O-glycans that are shut down during the differentiation process. In contrast, during TGC maturation, short glycans are increasingly synthesized. Due to the numerous biological functions of O-glycans (see [46, 48] for reviews), this might have far-reaching consequences for the cells, for example, through differently modified secreted ECM components or cell surface proteins that are involved in recognition modulation, cell adhesion and communication between cells and their environment. Sialylated glycans often function as self-associated molecular patterns (SAMPs) that attenuate immune defense via interactions with inhibitory siglecs [49]. Thus, TGCs might evade maternal immune defense by increasing the expression of sialylated core 1 O-glycans on the cell surface. In addition to these general aspects of sialic acids, overexpression of ST3GAL1 is specifically known to increase the migration and invasion capacity in ovarian cancer [50]. Based on numerous studies demonstrating a direct link between ST3GAL1 overexpression and tumorigenesis, it is more likely that comparable effects, such as enhanced migration properties, may also take place in TGCs when ST3GAL1 is upregulated.

Fig. 4

Schematic representation of structural changes in mucin type O-glycans associated with the differentiation of UTCs into TGCs. Green and red arrows indicate up- and downregulated reactions, respectively. The numbers next to the arrows stand for DEG-encoded enzymes catalyzing the addition of the different sugars (GALNTs, N-acetylgalactosaminyltransferases; C1GALT, core 1 beta1,3-galactosyltransferase; GCNTs, beta1,6-N-acetylglucosaminyltransferases; B3GNT6, beta1,3-N-acetylglucosaminyltransferase 6; ST3GAL4, ST3 beta-galactoside alpha2,3-sialyltransferase 4). More details are given in the text. (GalNAc, N-acetylgalactosamine; Gal, galactose; GlcNAc, N-acetylgucosamine; SIA, sialic acid). (Modified from [45])


From the results of our microarray data, a number of experimentally verifiable hypotheses could be derived:

  1. 1.

    The bovine trophoblast produces PRL, primarily in the TGCs.

  2. 2.

    ECM composition and cell surface receptors differ significantly between UTCs and TGCs, which affects signal transduction and downstream processes.

  3. 3.

    TGCs produce increased amounts of sialylated short-chain O-glycans, while UTCs can form complex, high-molecular-weight O-glycans.


Bovine UTCs and TGCs

Virtually pure UTCs and TGCs were obtained from bovine placentas from days 118 to 130 of gestation in an earlier study [11] with an optimized fluorescence activated cell sorting (FACS) method. Trophoblast cell isolates from three placentas (#2, #3 and #4) provided sufficient amounts of total RNA for the microarray analysis of this study.

RNA preparation, cRNA production and labeling, and microarray hybridization

Total RNA for the microarray analysis was extracted from UTCs and TGCs with the NucleoSpin RNA II Kit as described by the manufacturer (Macherey-Nagel, Düren, Germany). RNA was quantified in a NanoDrop 1000 spectrophotometer (PeqLab, Erlangen, Germany) and RNA quality was assessed in a 2100 Bioanalyzer instrument using the RNA 6000 Pico Kit and 2100 Expert Software (Agilent Technologies, Santa Clara, CA, USA). RNA integrity numbers were between 7.2 and 8.8. For RNA processing, labeling and hybridization the respective reagent kits from Affymetrix (Santa Clara, USA) were used as recommended by the supplier. Briefly, 120 ng of total RNA from each cell sample was used for single strand DNA (ssDNA) generation using the Ambion WT (whole transcript) Expression Kit (Thermo Fisher Scientific, Waltham, MA, USA). Fragmentation and labeling were performed using the Affymetrix Gene Chip WT Terminal Labeling and Hybridization Kit. The enzymatically fragmented and end labeled ssDNAs were hybridized to Affymetrix Bovine Gene 1.0 ST Arrays for 16 h at 45 °C in an Affymetrix Gene Chip Hybridization Oven. The microarrays were scanned at a 0.7-μm resolution with the Affymetrix Gene Chip Scanner 3000 7G. The data sets from the microarray experiments have been submitted to the Gene Expression Omnibus (GEO) database (accession number GSE122474).

Analysis of microarray data

The microarray data were analyzed with the Biometric Research Branch (BRB) Array Tools version 4.4.1 []. Background correction and normalization of the expression values was performed using the GC Robust Multi-Array Average (GC RMA) algorithm [51]. Per definition, transcripts were considered differentially expressed among UTC and TGC groups if fold-change values were ≤ − 1.5 or ≥ 1.5 and the p-value of the univariate t-test between values paired according the UTC and TGC preparations was < 0.05. False discovery rates (FDR) were calculated but not used as a cut-off criterion.

The DEGs were subjected to gene ontology (GO) term analyses using Database for Annotation, Visualization and Integrated Discovery (DAVID) 6.8 software [52, 53]. To this end, our DEG list was first converted into a DAVID compliant gene list using the Gene List Manager. The pathway analyses were based on the Kyoto Encyclopedia of Genes and Genomes (KEGG) database.

Reverse transcription of RNA; PCR and quantitative reverse-transcription PCR (qPCR)

Microarray measurements were validated by qPCR measurements of selected transcripts. To this end, total RNA (100 ng) from the UTCs or TGCs was reverse transcribed in a 25-μl reaction volume using a mixture of random hexameric and oligo dT primers (4 and 2 ng/μl, respectively; Roche, Mannheim, Germany) and M-MLV reverse transcriptase (GeneOn, Ludwigshafen, Germany). Complementary DNA was purified with the High Pure PCR Product Purification Kit (Roche). Standard PCR to test the specificity of the primer pairs was conducted in 25 μl reaction buffer containing cDNA, Fast Start Taq DNA Polymerase (MP Biomedicals, Illkirch, France), dNTPs (Roche) and gene-specific primers (Additional file 1: Table S1-F). The cycling conditions were as follows: preincubation at 94 °C for 5 min followed by 30 cycles of denaturation at 95 °C for 5 min, annealing at 60 °C for 1 min, extension at 70 °C for 2 min, and a final elongation at 70 °C for 5 min. The PCR products were verified by cloning and sequencing. For qPCR, cDNA was amplified in a 12-μl reaction volume with the SensiFast SYBR No-ROX Kit (Bioline, Luckenwalde, Germany) and gene-specific primer pairs. For amplification and quantification of the PCR products a Light-Cycler 480 instrument (Roche) was used with the following cycling conditions: preincubation at 95 °C for 5 min, followed by 40 cycles of denaturation at 95 °C for 20 s, annealing at 60 °C for 15 s, and extension at 72 °C for 15 s, and single point fluorescence acquisition at 75 °C for 10 s to avoid quantifying primer artifacts. The generation of only the expected products was confirmed by melting curve analysis and agarose gel electrophoresis. External standard curves were generated by coamplification of various dilutions of cloned PCR products (5 × 10− 12 to 5 × 10− 16 g DNA/reaction) with the corresponding primer pairs. Transcript abundance measurements were normalized using the RPS18 transcript as an internal reference.

Statistical analyses were performed with SigmaPlot 12.0 Statistical Analysis System (Jandel Scientific, San Rafael, California, USA). Significance of differences was assessed using the t-test, and p-values < 0.05 were considered statistically significant. Pearson’s product moment correlation was used to compare microarray and qPCR data.

Availability of data and materials

The data sets from the microarray experiments have been submitted to the Gene Expression Omnibus (GEO) database (accession number GSE122474).


  1. 1.

    Oliveira LJ, Barreto RS, Perecin F, Mansouri-Attia N, Pereira FT, Meirelles FV. Modulation of maternal immune system during pregnancy in the cow. Reprod Domest Anim. 2012;47(Suppl 4):384–93.

    PubMed  Article  PubMed Central  Google Scholar 

  2. 2.

    Schuler G, Fürbass R, Klisch K. Placental contribution to the endocrinology of gestation and parturition. Animal Reproduction. 2018;15(Supplement 1):822–42.

    Article  Google Scholar 

  3. 3.

    Bjorkman N. Morphological and histochemical studies on the bovine placenta. Acta Anat (Basel). 1954;22:1–91.

    CAS  Article  Google Scholar 

  4. 4.

    Leiser R. Development of contact between trophoblast and uterine epithelium during the early stages on implantation in the cow. Zentralblatt fur Veterinarmedizin Reihe C: Anatomie, Histologie, Embryologie. 1975;4(1):63–86.

    CAS  Google Scholar 

  5. 5.

    Leiser R, Kaufmann P. Placental structure: in a comparative aspect. Exp Clin Endocrinol. 1994;102(3):122–34.

    CAS  PubMed  Article  Google Scholar 

  6. 6.

    Wooding FB. Current topic: the synepitheliochorial placenta of ruminants: binucleate cell fusions and hormone production. Placenta. 1992;13(2):101–13.

    CAS  PubMed  Article  Google Scholar 

  7. 7.

    Wooding FB, Wathes DC. Binucleate cell migration in the bovine placentome. J Reprod Fertil. 1980;59(2):425–30.

    CAS  PubMed  Article  Google Scholar 

  8. 8.

    Klisch K, Hecht W, Pfarrer C, Schuler G, Hoffmann B, Leiser R. DNA content and ploidy level of bovine placentomal trophoblast giant cells. Placenta. 1999;20(5–6):451–8.

    CAS  PubMed  Article  Google Scholar 

  9. 9.

    Klisch K, Pfarrer C, Schuler G, Hoffmann B, Leiser R. Tripolar acytokinetic mitosis and formation of feto-maternal syncytia in the bovine placentome: different modes of the generation of multinuclear cells. Anat Embryol (Berl). 1999;200(2):229–37.

    CAS  Article  Google Scholar 

  10. 10.

    Klisch K, Leiser R. In bovine binucleate trophoblast giant cells, pregnancy-associated glycoproteins and placental prolactin-related protein-I are conjugated to asparagine-linked N-acetylgalactosaminyl glycans. Histochem Cell Biol. 2003;119(3):211–7.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  11. 11.

    Polei M, Viergutz T, Tomek W, Schuler G, Furbass R. Estrogen-specific sulfotransferase (SULT1E1) in bovine placentomes: inverse levels of mRNA and protein in uninucleated trophoblast cells and trophoblast giant cells. Biol Reprod. 2014;91(2):48.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  12. 12.

    Cornelis G, Heidmann O, Degrelle SA, Vernochet C, Lavialle C, Letzelter C, Bernard-Stoecklin S, Hassanin A, Mulot B, Guillomot M, et al. Captured retroviral envelope syncytin gene associated with the unique placental structure of higher ruminants. Proc Natl Acad Sci U S A. 2013;110(9):E828–37.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  13. 13.

    Telugu BP, Walker AM, Green JA. Characterization of the bovine pregnancy-associated glycoprotein gene family--analysis of gene sequences, regulatory regions within the promoter and expression of selected genes. BMC Genomics. 2009;10:185.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  14. 14.

    Green JA, Xie S, Quan X, Bao B, Gan X, Mathialagan N, Beckers JF, Roberts RM. Pregnancy-associated bovine and ovine glycoproteins exhibit spatially and temporally distinct expression patterns during pregnancy. Biol Reprod. 2000;62(6):1624–31.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  15. 15.

    Touzard E, Reinaud P, Dubois O, Guyader-Joly C, Humblot P, Ponsart C, Charpigny G. Specific expression patterns and cell distribution of ancient and modern PAG in bovine placenta during pregnancy. Reproduction. 2013;146(4):347–62.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  16. 16.

    Wallace RM, Pohler KG, Smith MF, Green JA. Placental PAGs: gene origins, expression patterns, and use as markers of pregnancy. Reproduction. 2015;149(3):R115–26.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  17. 17.

    Wooding FB, Roberts RM, Green JA. Light and electron microscope immunocytochemical studies of the distribution of pregnancy associated glycoproteins (PAGs) throughout pregnancy in the cow: possible functional implications. Placenta. 2005;26(10):807–27.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  18. 18.

    Ben David E, Shemesh M. Ultrastructural localization of cytochrome P-450scc in the bovine placentome using protein A-gold technique. Biol Reprod. 1990;42(1):131–8.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  19. 19.

    Schuler G, Greven H, Kowalewski MP, Doring B, Ozalp GR, Hoffmann B. Placental steroids in cattle: hormones, placental growth factors or by-products of Trophoblast Giant cell differentiation? Exp Clin Endocrinol Diabetes. 2008;116:429–36.

    CAS  Article  Google Scholar 

  20. 20.

    Schuler G, Ozalp GR, Hoffmann B, Harada N, Browne P, Conley AJ. Reciprocal expression of 17alpha-hydroxylase-C17,20-lyase and aromatase cytochrome P450 during bovine trophoblast differentiation: a two-cell system drives placental oestrogen synthesis. Reproduction. 2006;131(4):669–79.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  21. 21.

    Vanselow J, Fürbass R, Tiemann U. Cultured bovine trophoblast cells differentially express genes encoding key steroid synthesis enzymes. Placenta. 2008;29:531–8.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  22. 22.

    Soares MJ. The prolactin and growth hormone families: pregnancy-specific hormones/cytokines at the maternal-fetal interface. Reprod Biol Endocrinol. 2004;2:51.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  23. 23.

    Patel OV, Yamada O, Kizaki K, Todoroki J, Takahashi T, Imai K, Schuler LA, Hashizume K. Temporospatial expression of placental lactogen and prolactin-related protein-1 genes in the bovine placenta and uterus during pregnancy. Mol Reprod Dev. 2004;69(2):146–52.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  24. 24.

    Ushizawa K, Takahashi T, Hosoe M, Ishiwata H, Kaneyama K, Keiichiro K, Hashizume K. Global gene expression analysis and regulation of the principal genes expressed in bovine placenta in relation to the transcription factor AP-2 family. Reprod Biol Endocrinol. 2007;5(1):17.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  25. 25.

    Wilsher S, Stansfield F, Greenwood RE, Trethowan PD, Anderson RA, Wooding FB, Allen WR. Ovarian and placental morphology and endocrine functions in the pregnant giraffe (Giraffa camelopardalis). Reproduction. 2013;145(6):541–54.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  26. 26.

    Yamamoto Y, Yamamoto T, Yuto N, Hildebrandt TB, Lueders I, Wibbelt G, Shiina O, Mouri Y, Sugimura K, Sakamoto S, et al. The secretory pattern and source of immunoreactive prolactin in pregnant African (Loxodonta africana) and Asian (Elephas maximus) elephants. J Reprod Dev. 2012;58(1):105–11.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  27. 27.

    Featherstone K, White MR, Davis JR. The prolactin gene: a paradigm of tissue-specific gene regulation with complex temporal transcription dynamics. J Neuroendocrinol. 2012;24(7):977–90.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  28. 28.

    Bernichtein S, Touraine P, Goffin V. New concepts in prolactin biology. J Endocrinol. 2010;206(1):1–11.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  29. 29.

    Frantz C, Stewart KM, Weaver VM. The extracellular matrix at a glance. J Cell Sci. 2010;123(Pt 24):4195–200.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  30. 30.

    Kadler KE, Baldock C, Bella J, Boot-Handford RP. Collagens at a glance. J Cell Sci. 2007;120(Pt 12):1955–8.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  31. 31.

    Cescon M, Gattazzo F, Chen P, Bonaldo P. Collagen VI at a glance. J Cell Sci. 2015;128(19):3525–31.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  32. 32.

    Humphries JD, Byron A, Humphries MJ. Integrin ligands at a glance. J Cell Sci. 2006;119(Pt 19):3901–3.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  33. 33.

    Bonaldo P, Braghetta P, Zanetti M, Piccolo S, Volpin D, Bressan GM. Collagen VI deficiency induces early onset myopathy in the mouse: an animal model for Bethlem myopathy. Hum Mol Genet. 1998;7(13):2135–40.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  34. 34.

    Colognato H, Yurchenco PD. Form and function: the laminin family of heterotrimers. Dev Dyn. 2000;218(2):213–34.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  35. 35.

    Aumailley M, Bruckner-Tuderman L, Carter WG, Deutzmann R, Edgar D, Ekblom P, Engel J, Engvall E, Hohenester E, Jones JC, et al. A simplified laminin nomenclature. Matrix Biol. 2005;24(5):326–32.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  36. 36.

    Harburger DS, Calderwood DA. Integrin signalling at a glance. J Cell Sci. 2009;122(Pt 2):159–63.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  37. 37.

    Damsky CH, Fitzgerald M, Fisher S. Distribution patterns of extracellular matrix components and adhesion receptors are intricately modulated during first trimester cytotrophoblast differentiation along the invasive pathway, in vivo. J Clin Invest. 1992;89(1):210–22.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  38. 38.

    Damsky CH, Librach C, Lim K-H, Fitzgerald ML, McMaster MT, Janatpour M, Zhou Y, Logan SK, Fisher SJ. Integrin switching regulates normal trophoblast invasion. Development. 1994;120(12):3657–66.

    CAS  PubMed  PubMed Central  Google Scholar 

  39. 39.

    Pfarrer C, Hirsch P, Guillomot M, Leiser R. Interaction of integrin receptors with extracellular matrix is involved in trophoblast giant cell migration in bovine placentomes. Placenta. 2003;24(6):588–97.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  40. 40.

    Kizaki K, Nakano H, Nakano H, Takahashi T, Imai K, Hashizume K. Expression of heparanase mRNA in bovine placenta during gestation. Reproduction-Cambridge. 2001;121(4):573–80.

    CAS  Article  Google Scholar 

  41. 41.

    Apte SS, Parks WC. Metalloproteinases: a parade of functions in matrix biology and an outlook for the future. Matrix Biol. 2015;44:1–6.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  42. 42.

    Russell DL, Brown HM, Dunning KR. ADAMTS proteases in fertility. Matrix Biol. 2015;44:54–63.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  43. 43.

    Arpino V, Brock M, Gill SE. The role of TIMPs in regulation of extracellular matrix proteolysis. Matrix Biol. 2015;44:247–54.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  44. 44.

    Brockhausen I, Stanley P. O-GalNAc Glycans. In: Essentials of Glycobiology [Internet] 3rd edition. Varki A, Cummings RD, Esko JD, et al., editors. Cold Spring Habor (NY): Cold Spring Harbor Laboratory Press; 2015–2017. 2017.

  45. 45.

    Tran DT, Ten Hagen KG. Mucin-type O-glycosylation during development. J Biol Chem. 2013;288(10):6921–9.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  46. 46.

    Bennett EP, Mandel U, Clausen H, Gerken TA, Fritz TA, Tabak LA. Control of mucin-type O-glycosylation: a classification of the polypeptide GalNAc-transferase gene family. Glycobiology. 2012;22(6):736–56.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  47. 47.

    Picco G, Julien S, Brockhausen I, Beatson R, Antonopoulos A, Haslam S, Mandel U, Dell A, Pinder S, Taylor-Papadimitriou J. Over-expression of ST3Gal-I promotes mammary tumorigenesis. Glycobiology. 2010;20(10):1241–50.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  48. 48.

    Chia J, Goh G, Bard F. Short O-GalNAc glycans: regulation and role in tumor development and clinical perspectives. Biochim Biophys Acta. 2016;1860(8):1623–39.

    CAS  PubMed  Article  Google Scholar 

  49. 49.

    Lübbers J, Rodríguez E, Van Kooyk Y. Modulation of immune tolerance via Siglec-sialic acid interactions. Front Immunol. 2018;9:2807.

  50. 50.

    Wu X, Zhao J, Ruan Y, Sun L, Xu C, Jiang H. Sialyltransferase ST3GAL1 promotes cell migration, invasion, and TGF-β1-induced EMT and confers paclitaxel resistance in ovarian cancer. Cell Death Dis. 2018;9(11):1102.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  51. 51.

    Wu Z, Irizarry RA, Gentleman R, Martinez-Murillo F, Spencer F. A model-based background adjustment for oligonucleotide expression arrays. J Am Stat Assoc. 2004;99(468):909–17.

    Article  Google Scholar 

  52. 52.

    Huang DW, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2008;37(1):1–13.

    PubMed Central  Article  CAS  Google Scholar 

  53. 53.

    Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4:44–57.

    CAS  Article  Google Scholar 

Download references


We thank Maren Anders and Veronica Schreiter for their excellent technical support. We are grateful to Dr. Sebastian Galuska for the helpful discussion on O-glycans and Dr. Anja Baufeld for critically reviewing the manuscript.


This study was supported by grant Fu335/3–1 from the Deutsche Forschungsgemeinschaft (DFG). The funding body did not participate in the conception of the study, the collection, analysis and interpretation of the data or in the preparation of the manuscript.

Author information




MP contributed to data analysis and interpretation. JG contributed to data analysis and drafting of the manuscript. DK prepared the microarray hybridizations. RF designed the study, analyzed and interpreted the data and drafted the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Rainer Fürbass.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Additional file 1: Table S1-A.

List of differentially expressed genes (DEGs) between UTCs and TGCs obtained by analyzing microarray data with the BRB Array Tools. Table S1-B. Correlation between the microarray and quantitative reverse transcription PCR measurements. Table S1-C. List of DAVID IDs generated from the BRB list of DEGs (Table S1-A) using the DAVID Gene List Manager. Table S1-D. KEGG pathways that are involved in the differentiation of UTCs into TGCs and associated DEGs. Table S1-E. Annotation clusters of GO terms related to UTC differentiation into TGCs and associated DEGs (enrichment score > 2). Table S1-F. Sequences of primers used for PCR and quantitative reverse transcription PCR.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Polei, M., Günther, J., Koczan, D. et al. Trophoblast cell differentiation in the bovine placenta: differentially expressed genes between uninucleate trophoblast cells and trophoblast giant cells are involved in the composition and remodeling of the extracellular matrix and O-glycan biosynthesis. BMC Mol and Cell Biol 21, 1 (2020).

Download citation


  • UTC
  • TGC
  • GO analysis
  • ECM
  • Cell migration
  • Signal transduction